Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,551 stories, page 42 of 810

Advanced search

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07574918: Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07570173: A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07525986: Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07513376: A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07484269: PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07406620: Entropy-based Physiological Signal Analysis in Patients With Obstructive Sleep Apnoea

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07399574: Diagnostic Accuracy of A Diquat Quantitative Detection Kit and A Portable Mass Spectrometry System for Quantifying Diquat Concentrations in Human Blood Samples

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07173751: ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT07167914: A Study to Assess Safety, Tolerability and Pharmacokinetics of Transdermal SFG-02 in Healthy Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06961344: An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06948110: Deciphering the Genetic Architecture of Autoimmune Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06922318: The COSMYC Trial (COmbined Suppression of MYC)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06906380: A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06499870: Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06487481: Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06229990: Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT06151392: Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients With Ventriculitis

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05975307: Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05928936: Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05866432: Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05763251: Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05714085: Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05648500: A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05635708: A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05455697: Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT05303467: A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT04644289: WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT04613596: Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸6d agoResearchclinicaltrials.govTier 1 · Trial registry

NCT03047135: Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Boulder’s Transformative Biotech opens research lab at Alabama incubator

ColoradoBizOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, I (WST) Stock Forecasts

Yahoo FinanceOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. (WST) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance CanadaOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Grand Pharmaceutical Group Limited (0512.HK) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance CanadaOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Shanghai Henlius Biotech, Inc. (2696.HK) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance CanadaOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

FDA approves Zanvastro, 1st drug directly targeting Alexander disease

NewsBytesOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Get the Facts: Ad attacks Ramaswamy over pharmaceutical drug venture — context behind claims

WLWTOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Trump Admin Gears Up for Post-Midterm Crackdown on Abortion Drug - TPM

Talking Points MemoOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. Q3 2026 Earnings Call Summary

Yahoo FinanceOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Pre-APEC US ban on Chinese genomic giant widens biotech decoupling

Asia TimesOriginal source

🌍6d agoIndustryexozymes.comTier 1 · Company source

WTR fireside chat & report: CEO Discusses the Road to Commercialization

eXoZymesOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

China Upends Global Drug Development With Cheap and Rapid Human Trials

BloombergOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

What Does ‘In Clinical Trial’ Actually Mean? – Ovarian Cancer Research Foundation

OncodailyOriginal source

🇧🇷6d agoResearchufrj.brTier 2 · Direct publisher

Claudio Luiz Baraúna Vieira recebe título de professor emérito da UFRJ

UFRJ BrazilOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

FDA announces Proposed Rule for Infant Formula Nutrient Requirements and Released Chemical Contaminant Testing Data

FoodSafetyTechOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

HHS will permit compounding of six peptides ahead of formal rulemaking

RAPSOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?

Zacks Investment ResearchOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Kodak expands pharmaceutical supplies made in Rochester - RBJ

Rochester Business JournalOriginal source

🌍6d agoIndustrynews.intermountainhealth.orgTier 3 · Secondary coverage

Butte Woman Shares the Importance of Self-Exams and Awareness After Breast Cancer Treatment at Intermountain Health St. James Hospital

<![CDATA[Intermountain Health Newsroom]]>Original source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Proposed COINS Act Rules for China Biotech Deals: Why Transaction Structure Matters

Morgan LewisOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition

New York PostOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

What DOL’s Final PBM Rule Means for Rebates and Formularies

Pharmaceutical CommerceOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Recon: FDA approves Stada’s Lucentis biosimilar; Lilly says ‘triple-G’ candidate bests Ozempic in diabetes

RAPSOriginal source

🇧🇷6d agoIndustryems.com.brTier 1 · Company source

EMS lança plataforma de patrocínios para receber projetos em cinco áreas

EMS Pharma NewsOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Alnylam Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Period Progress

AlnylamOriginal source

🇧🇷6d agoIndustryems.com.brTier 1 · Company source

EMS é campeã da categoria Farmacêutico e Beleza na 53ª edição do Prêmio Melhores e Maiores da Exame

EMS Pharma NewsOriginal source

🇨🇦6d agoCROaltasciences.comTier 2 · Direct publisher

Breakthroughs in Cell + Gene Therapy

AltasciencesOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

FDA approves first drug for Alexander disease — ScienceAlert

UA.NEWSOriginal source

🌍6d agodiscoverynews.google.comTier 3 · Aggregated media

Phase 3 trial launches to evaluate new treatment for Fabry disease

Fabry Disease NewsOriginal source

🌍6d agoIndustryscripps.orgTier 1 · Company source

Breast Reconstruction After Mastectomy: What Are Your Options?

Scripps HealthOriginal source